Φορτώνει......
Rhaponticin suppresses osteosarcoma through the inhibition of PI3K-Akt-mTOR pathway
Osteosarcoma is the frequent pediatric bone cancer where pediatric osteosarcoma incidences are more than 10% within the population. Most of the patients with osteosarcoma fall within the age of 15–30 years. Therefore, in this research, we examined the anticancer effect of Rhaponticin against the hum...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Saudi J Biol Sci |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Elsevier
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8241634/ https://ncbi.nlm.nih.gov/pubmed/34220214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.sjbs.2021.05.006 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|